The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - SERVIER

mTORC1 activation assessed in metastatic sample to predict outcome in patients with metastatic breast cancer treated with everolimus-exemestan: Results from the SAFIRTOR study.
 
Thomas Denis Bachelot
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; pfizer; Roche
 
Isabelle Treilleux
No Relationships to Disclose
 
Camille Schiffler
No Relationships to Disclose
 
Ivan Bieche
No Relationships to Disclose
 
Mario Campone
Honoraria - Menarini; Novartis; Servier
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Sanofi (Inst); SERVIER (Inst)
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Roche
 
Anne Patsouris
Travel, Accommodations, Expenses - Eisai; Pfizer; Roche
 
Monica Arnedos
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Seagen
Research Funding - Lilly; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Paul H. Cottu
Honoraria - AstraZeneca; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - Lilly; Lilly; Novartis; pfizer; Roche
 
Jean-Philippe Jacquin
No Relationships to Disclose
 
Florence Dalenc
No Relationships to Disclose
 
Valéry Attignon
No Relationships to Disclose
 
Etienne Rouleau
No Relationships to Disclose
 
Alain Morel
No Relationships to Disclose
 
François Legrand
No Relationships to Disclose
 
Marta Jimenez
No Relationships to Disclose
 
Fabrice Andre
Research Funding - AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche